Aggregated
50% success rate- Bullish
- 0
- Hold
- 0
- Bearish
- 0
Cowen & Co.
A Cowen & Co. analyst with 5 tracked ratings across 5 distinct tickers has a 50% success rate on the captured sample, covering two sources with the last rating issued on December 1, 2022.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| SCPHSCPHARMACEUTICALS INC | 2022-12-01 | unknown | $25.00 | Aggregated |
| TAK | 2022-07-19 | buy | $24.00 | Aggregated |
| TAKTAKEDA PHARMACEUTICAL CO - ADR | 2022-07-19 | unknown | $24.00 | Aggregated |
| BLCOBAUSCH + LOMB CORP | 2022-05-11 | unknown | $35.00 | Aggregated |
| MOLNMOLECULAR PARTNERS AG - ADR | 2021-07-13 | unknown | $50.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| SCPHSCPHARMACEUTICALS INC | 1 | 2022-12-01 | Aggregated |
| TAK | 1 | 2022-07-19 | Aggregated |
| TAKTAKEDA PHARMACEUTICAL CO - ADR | 1 | 2022-07-19 | Aggregated |
| BLCOBAUSCH + LOMB CORP | 1 | 2022-05-11 | Aggregated |
| MOLNMOLECULAR PARTNERS AG - ADR | 1 | 2021-07-13 | Aggregated |